XVIPF OTC
Xvivo Perfusion AB (publ)
1W: -12.8%
1M: -29.6%
3M: -24.8%
YTD: +5.3%
1Y: +14.4%
3Y: -4.0%
5Y: -31.8%
$21.80
-1.05 (-4.60%)
Weekly Expected Move ±9.7%
$18
$20
$22
$24
$26
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$101M
-9.4% ▼
Capital Expenditures
$101M
-42.5% ▼
5Y CAGR: +9.3%
Free Cash Flow
$0
-100.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$53M
+59.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $7M | $22M | $92M | $200M | $25M |
| Depreciation & Amort. | $32M | $42M | $76M | $0 | $70M |
| Stock-Based Comp. | $3M | $0 | $2M | $0 | $0 |
| Change in Working Capital | -$23M | -$22M | -$39M | -$79M | -$69M |
| Other Non-Cash Items | -$28M | -$14M | -$85M | -$10M | $74M |
| Operating Cash Flow | -$12M | $28M | $46M | $111M | $101M |
| — Investing Activities — | |||||
| Capital Expenditures | -$94M | -$131M | -$43M | $0 | $0 |
| Acquisitions (Net) | -$93M | -$67M | -$18M | $0 | $0 |
| Investment Purchases | -$401K | $113M | $0 | $0 | $0 |
| Investment Sales | $84M | $769K | $0 | $0 | $0 |
| Other Investing | -$84M | -$113M | -$101M | -$244M | -$258M |
| Investing Cash Flow | -$188M | -$198M | -$162M | -$244M | -$258M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$6M | $0 | $0 | -$11M | $0 |
| Stock Repurchased | $0 | -$368K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$5M | -$7M | -$11M | $0 | $72M |
| Financing Cash Flow | $235M | -$7M | $419M | -$11M | $72M |
| Net Change in Cash | $44M | -$152M | $300M | -$131M | -$53M |
| Cash End of Period | $399M | $247M | $546M | $416M | $291M |
| Free Cash Flow | -$106M | -$103M | -$98M | $41M | $0 |